| Systematic review of complications of prostate biopsy S Loeb, A Vellekoop, HU Ahmed, J Catto, M Emberton, R Nam, ... European urology 64 (6), 876-892, 2013 | 1254 | 2013 |
| Overdiagnosis and overtreatment of prostate cancer S Loeb, MA Bjurlin, J Nicholson, TL Tammela, DF Penson, HB Carter, ... European urology 65 (6), 1046-1055, 2014 | 1092 | 2014 |
| Complications after prostate biopsy: data from SEER-Medicare S Loeb, HB Carter, SI Berndt, W Ricker, EM Schaeffer The Journal of urology 186 (5), 1830-1834, 2011 | 819 | 2011 |
| A multicenter study of [-2] pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to … WJ Catalona, AW Partin, MG Sanda, JT Wei, GG Klee, CH Bangma, ... The Journal of urology 185 (5), 1650-1655, 2011 | 617 | 2011 |
| Complications after systematic, random, and image-guided prostate biopsy M Borghesi, H Ahmed, R Nam, E Schaeffer, R Schiavina, S Taneja, ... European urology 71 (3), 353-365, 2017 | 551 | 2017 |
| Infectious complications and hospital admissions after prostate biopsy in a European randomized trial S Loeb, S van den Heuvel, X Zhu, CH Bangma, FH Schröder, MJ Roobol European urology 61 (6), 1110-1114, 2012 | 397 | 2012 |
| The prostate health index selectively identifies clinically significant prostate cancer S Loeb, MG Sanda, DL Broyles, SS Shin, CH Bangma, JT Wei, AW Partin, ... The Journal of urology 193 (4), 1163-1169, 2015 | 333 | 2015 |
| Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program AE Ross, S Loeb, P Landis, AW Partin, JI Epstein, A Kettermann, Z Feng, ... Journal of Clinical Oncology 28 (17), 2810-2816, 2010 | 326 | 2010 |
| Characteristics of prostate cancer detected by digital rectal examination only OT Okotie, KA Roehl, M Han, S Loeb, SN Gashti, WJ Catalona Urology 70 (6), 1117-1120, 2007 | 309 | 2007 |
| The Prostate Health Index: a new test for the detection of prostate cancer S Loeb, WJ Catalona Therapeutic advances in urology 6 (2), 74-77, 2014 | 304 | 2014 |
| Dissemination of misinformative and biased information about prostate cancer on YouTube S Loeb, S Sengupta, M Butaney, JN Macaluso Jr, SW Czarniecki, ... European urology 75 (4), 564-567, 2019 | 300 | 2019 |
| Biomarkers for prostate cancer DV Makarov, S Loeb, RH Getzenberg, AW Partin Annual review of medicine 60 (1), 139-151, 2009 | 259 | 2009 |
| An update of the American Urological Association white paper on the prevention and treatment of the more common complications related to prostate biopsy MA Liss, B Ehdaie, S Loeb, MV Meng, JD Raman, V Spears, SP Stroup The Journal of urology 198 (2), 329-334, 2017 | 258 | 2017 |
| Implementation of germline testing for prostate cancer: Philadelphia Prostate Cancer Consensus Conference 2019 VN Giri, KE Knudsen, WK Kelly, HH Cheng, KA Cooney, MS Cookson, ... Journal of Clinical Oncology 38 (24), 2798-2811, 2020 | 255 | 2020 |
| Active surveillance for prostate cancer: current evidence and contemporary state of practice JJ Tosoian, HB Carter, A Lepor, S Loeb Nature Reviews Urology 13 (4), 205-215, 2016 | 253 | 2016 |
| Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators MJ Roobol, HA van Vugt, S Loeb, X Zhu, M Bul, CH Bangma, ... European urology 61 (3), 577-583, 2012 | 232 | 2012 |
| Genomic predictors of outcome in prostate cancer PJ Boström, AS Bjartell, JWF Catto, SE Eggener, H Lilja, S Loeb, ... European urology 68 (6), 1033-1044, 2015 | 217 | 2015 |
| Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old S Loeb, KA Roehl, JAV Antenor, WJ Catalona, BK Suarez, RB Nadler Urology 67 (2), 316-320, 2006 | 214 | 2006 |
| Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification S Loeb, SM Bruinsma, J Nicholson, A Briganti, T Pickles, Y Kakehi, ... European urology 67 (4), 619-626, 2015 | 204 | 2015 |
| Development and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancer DE Spratt, J Zhang, M Santiago-Jiménez, RT Dess, JW Davis, RB Den, ... Journal of Clinical Oncology 36 (6), 581-590, 2018 | 203 | 2018 |
